Patrys : 30 September 2015 - Corporate Restructure & Change in Company Secretary

ASX & Media Release

ASX & Media Release

Corporate Restructure and Change of Company Secretary

Melbourne, Australia; 30 September, 2015: Patrys Limited (ASX: PAB) advises that it has undertaken a review of its corporate structure and overheads, and as noted in its 2015 Annual Report has decided to close its German facility from the end of 2015. In addition, Mr Roger McPherson will retire as Chief Operating Officer and Company Secretary as part of a corporate restructure initiative effective on 1 October 2015. Ms Melanie Leydin will be appointed as Company Secretary effective from 1 October 2015.

Ms Leydin holds a Bachelor of Business majoring in Accounting and Corporate Law. She is a member of the Institute of Chartered Accountants and is a Registered Company Auditor. She graduated from Swinburne University in 1997, became a Chartered Accountant in 1999 and since February 2000 has been the principal of chartered accounting firm, Leydin Freyer. The practice provides outsourced company secretarial and accounting services to public and private companies specialising in the resources, technology, bioscience and biotechnology sectors.

The Patrys Board and management would like to take this opportunity to express their thanks to the staff of the Germany subsidiary, particularly Drs Frank Hensel and Stephanie Brändlein, for their efforts to discover and develop therapeutic IgM assets, a program of work which originated at the University of Würzburg.

The Board would also like to express its sincere thanks to Roger for his valued contribution to the Company since his commencement in October 2008, including his role as Chief Operating Officer and as Interim Chief Executive Officer last year, and wish him well for his future endeavours.

-Ends-

For further information, please contact:

Patrys Limited: James Campbell	Patrys IR: Kyahn Williamson	Patrys Media: Kellie Hanrick
Chief Executive Officer	Buchan Consulting	Buchan Consulting
P: [phone] [e-mail]	P: [phone] [e-mail]	P: [phone] [e-mail]

About Patrys Limited:

Based in Melbourne, Australia, Patrys (ASX: PAB) is focused on the development of antibodies as therapies for cancer and other major diseases. Patrys has a pipeline of anti-cancer antibodies that enable both internal development and partnering opportunities. More information can be found at www.patrys.com

1